Loading...
 
Toggle Health Problems and D

Hypertension (both systolic and diastolic) reduced with 2,000 IU of vitamin D – RCT June 2014

Vitamin D and nifedipine in the treatment of Chinese patients with grades I–II essential hypertension: A randomized placebo-controlled trial

Atherosclerosis, Volume 235, Issue 1, Pages 102–109, July 2014, http://dx.doi.org/10.1016/j.atherosclerosis.2014.04.011
Wei Ren Chen1, Zhi Ying Liu1, Yang Shie chen_weiren at sina.com , Da Wei Yin, Hao Wang, Yuan Sha, Yun Dai Chen
1These authors contributed equally to this work.
Received: December 4, 2013; Received in revised form: March 28, 2014; Accepted: April 7, 2014; Published Online: April 30, 2014, DOI:

Highlights

•We planned to research the effect of vitamin D and nifedipine in the treatment of patients with essential hypertension.
•Vitamin D supplementation can reduce blood pressure in patients with hypertension.
•Vitamin D supplementation can be an adjuvant therapy for patients with grade I to II essential hypertension.

Objectives
Low vitamin D status has been shown to be associated with hypertension. We planned to research the effect of vitamin D and nifedipine in the treatment of patients with essential hypertension.

Methods
Patients with grades I–II essential hypertension were enrolled in this single-center, double-blind, placebo-controlled trial in Beijing. All patients received a conventional antihypertensive drug (nifedipine, 30 mg/d). One hundred and twenty-six patients were randomly assigned to receive vitamin D (n=63, 2000 IU/d) or a placebo (n=63) as an add-on to nifedipine, by the method of permutated block randomization. Ambulatory blood pressure monitoring was performed at baseline (month 0), at month 3 and at month 6.

Results
In vitamin D supplementation group, there was a significant increase in mean 25-hydroxyvitamin D levels from baseline (19.4±11.6 ng/ml) to 6 months (34.1±12.2 ng/ml; p<0.001). At 6 months, the primary end points, a difference in the fall of 24-h mean blood pressure, between the groups was

  • −6.2 mmHg (95% CI −11.2; −1.1) for systolic blood pressure (p<0.001) and
  • −4.2 mmHg (95% CI −8.8; −0.3) for diastolic blood pressure (p<0.001)

under intention to treat analysis.
In patients with vitamin D <30 ng/ml at baseline (n=113), 24-h mean blood pressure decreased by 7.1/5.7 mmHg (p<0.001). Safety and tolerability were similar among the two groups.

Conclusions
Vitamin D supplementation can reduce blood pressure in patients with hypertension, it can be an adjuvant therapy for patients with grades I–II essential hypertension.

Clinical Trial Registration: This study was registered in the Chinese Clinical Trial Registry, it is available in Website: http://www.chictr.org/cn/; Registration number: ChiCTR-ONC-13003840.


VitaminDWiki - Hypertension category contains

151 items in the category HYPERTENSION

see also
Overview Overview Hypertension and Vitamin D
Overview Cardiovascular and vitamin D
Overview Stroke and vitamin D
Incidence of 22 health problems related to vitamin D have doubled in a decade
Some interesting Hypertension studies


Title change made June 2022 caused the visitor count to reset.
There have actually been 5912 visitors to this page since it was originally made



Created by admin. Last Modification: Thursday June 23, 2022 20:05:26 GMT-0000 by admin. (Version 7)
See any problem with this page? Report it (WORKS NOV 2021)